Marketing-authorisation holder · United Kingdom
Emcure Pharmaceuticals Ltd.
9 medicines in 2 countries, as authorisation holder and manufacturer.
Group structure
Part of
EmcurePharmaceutical groupOther companies in the group
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
9 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BICNU | Carmustine | Saudi Arabia | Authorised | |
| ENCIFER 20MG/ML SOLU. FOR I.V. INJECTION | Iron sucrose | Saudi Arabia | Authorised | |
| IMTUS 20MG/ML SOL. FOR INFUSION | Irinotecan | Saudi Arabia | Authorised | |
| IMTUS 20MG/ML SOL. FOR INFUSION | Irinotecan | Saudi Arabia | Authorised | |
| Megval | Melphalan | Saudi Arabia | Authorised | |
| ABACAVIR || DOLUTEGRAVIR || LAMIVUDINE300mg | 50mg | 600mg · Tablet | Abacavir, Dolutegravir, Lamivudine | United States | tentative | 2024 |
| ATAZANAVIR SULFATE; RITONAVIR300mg; 100mg · Tablet | Atazanavir, Ritonavir | United States | tentative | 2014 |
| DOLUTEGRAVIR AND LAMIVUDINE300mg · Tablet | Dolutegravir, Lamivudine | United States | tentative | 2025 |
| LAMIVUDINE; ZIDOVUDINE150mg; 300mg | 150mg; 300mg; 600mg | 30mg; 60mg · Tablet | Lamivudine, Zidovudine | United States | tentative | 2006 |